Literature DB >> 27341035

Hepatitis B virus antigens impair NK cell function.

Yinli Yang1, Qiuju Han2, Cai Zhang2, Min Xiao3, Jian Zhang4.   

Abstract

An inadequate immune response of the host is thought to be a critical factor causing chronic hepatitis B virus (CHB) infection. Natural killer (NK) cells, as one of the key players in the eradication and control of viral infections, were functionally impaired in CHB patients, which might contribute to viral persistence. Here, we reported that HBV antigens HBsAg and HBeAg directly inhibited NK cell function. HBsAg and/or HBeAg blocked NK cell activation, cytokine production and cytotoxic granule release in human NK cell-line NK-92 cells, which might be related to the downregulation of activating receptors and upregulation of inhibitory receptor. Furthermore, the underlying mechanisms likely involved the suppression of STAT1, NF-κB and p38 MAPK pathways. These findings implicated that HBV antigen-mediated inhibition of NK cells might be an efficient strategy for HBV evasion, targeting the early antiviral responses mediated by NK cells and resulting in the establishment of chronic virus infection. Therefore, this study revealed the relationship between viral antigens and human immune function, especially a potential important interaction between HBV and innate immune responses.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HBeAg; HBsAg; NF-κB; Natural killer cell; STAT1; p38 MAPK

Mesh:

Substances:

Year:  2016        PMID: 27341035     DOI: 10.1016/j.intimp.2016.06.015

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection.

Authors:  Yadong Wang; Wei Wang; Chuan Shen; Yong Wang; Mingjing Jiao; Weiyan Yu; Hongzhu Yin; Xiaobo Shang; Qianfei Liang; Caiyan Zhao
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

Review 2.  Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?

Authors:  Jian Tang; Zhen-Yu Wu; Rong-Juan Dai; Jing Ma; Guo-Zhong Gong
Journal:  World J Clin Cases       Date:  2018-09-06       Impact factor: 1.337

Review 3.  The Interactions between HBV and the Innate Immunity of Hepatocytes.

Authors:  Fayed Attia Koutb Megahed; Xiaoling Zhou; Pingnan Sun
Journal:  Viruses       Date:  2020-03-05       Impact factor: 5.048

4.  The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy.

Authors:  Weihua Cao; Minghui Li; Lu Zhang; Yao Lu; Shuling Wu; Ge Shen; Min Chang; Ruyu Liu; Yuanjiao Gao; Hongxiao Hao; Leiping Hu; Wei Yi; Calvin Q Pan; Yao Xie
Journal:  Biomed Res Int       Date:  2021-01-25       Impact factor: 3.411

Review 5.  Innate and adaptive immune escape mechanisms of hepatitis B virus.

Authors:  Hua-Jun Zhao; Yi-Fei Hu; Qiu-Ju Han; Jian Zhang
Journal:  World J Gastroenterol       Date:  2022-03-07       Impact factor: 5.742

Review 6.  Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.

Authors:  Stanislaw Schmidt; Lars Tramsen; Bushra Rais; Evelyn Ullrich; Thomas Lehrnbecher
Journal:  Oncotarget       Date:  2018-04-17

7.  Serum HBV pregenomic RNA exhibited opposite associations with NKdim and NKbright cell immunity in treatment-naïve chronic hepatitis B patients.

Authors:  Yurong Gu; Zexuan Huang; Xiaoyan Li; Youming Chen; Chunhong Liao; Yanhua Bi; Yuehua Huang
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.